Literature DB >> 31014961

The isolation and characterization of a new snake venom cysteine-rich secretory protein (svCRiSP) from the venom of the Southern Pacific rattlesnake and its effect on vascular permeability.

Montamas Suntravat1, Walter E Cromer2, Jessenia Marquez3, Jacob A Galan3, David C Zawieja2, Peter Davies4, Emelyn Salazar3, Elda E Sánchez5.   

Abstract

A novel snake venom cysteine-rich secretory protein (svCRiSP), Hellerin, was purified from C. o. helleri venom using sequential reverse phase and cation-exchange chromatography. Gel electrophoresis, N-terminal sequencing, and LC-MS/MS sequencing identified a single protein with a molecular mass of approximately 24.8 kDa and confirmed its identity as a svCRiSP. Hellerin had cytotoxic effects on human umbilical vein endothelial cells (HUVECs) in a dose-dependent manner but not in human dermal lymphatic endothelial cells (HDLECs) and human dermal blood endothelial cells (HDBECs). Hellerin produced a dramatic increase in both blood vascular permeability in vivo, and in the trans-epithelial permeability of cultured HDLEC and HDBEC cells. This is the first study that describes the effect of a svCRiSP on vascular, blood and lymphatic permeability.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Lymphatic cells; Snake venom; Snake venom cysteine-rich secretory protein (svCRiSP); Southern pacific rattlesnake; Vascular permeability; Vasculature

Mesh:

Substances:

Year:  2019        PMID: 31014961      PMCID: PMC6556137          DOI: 10.1016/j.toxicon.2019.04.006

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  34 in total

1.  Different reactions of aortic and venular endothelial cell monolayers to histamine on macromolecular permeability: role of cAMP, cytosolic Ca2+ and F-actin.

Authors:  K Ikeda; N Utoguchi; H Makimoto; H Mizuguchi; S Nakagawa; T Mayumi
Journal:  Inflammation       Date:  1999-02       Impact factor: 4.092

Review 2.  Bacterial toxins modifying the actin cytoskeleton.

Authors:  J F Richard; L Petit; M Gibert; J C Marvaud; C Bouchaud; M R Popoff
Journal:  Int Microbiol       Date:  1999-09       Impact factor: 2.479

3.  iNOS upregulation mediates oxidant-induced disruption of F-actin and barrier of intestinal monolayers.

Authors:  A Banan; J Z Fields; Y Zhang; A Keshavarzian
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-06       Impact factor: 4.052

Review 4.  Structure and function of snake venom cysteine-rich secretory proteins.

Authors:  Yasuo Yamazaki; Takashi Morita
Journal:  Toxicon       Date:  2004-09-01       Impact factor: 3.033

5.  An ELISA for SGP28/CRISP-3, a cysteine-rich secretory protein in human neutrophils, plasma, and exocrine secretions.

Authors:  Lene Udby; Jack B Cowland; Anders H Johnsen; Ole E Sørensen; Niels Borregaard; Lars Kjeldsen
Journal:  J Immunol Methods       Date:  2002-05-01       Impact factor: 2.303

6.  Purification and cloning of toxins from elapid venoms that target cyclic nucleotide-gated ion channels.

Authors:  Yasuo Yamazaki; R Lane Brown; Takashi Morita
Journal:  Biochemistry       Date:  2002-09-24       Impact factor: 3.162

7.  Wide distribution of cysteine-rich secretory proteins in snake venoms: isolation and cloning of novel snake venom cysteine-rich secretory proteins.

Authors:  Yasuo Yamazaki; Fumiko Hyodo; Takashi Morita
Journal:  Arch Biochem Biophys       Date:  2003-04-01       Impact factor: 4.013

8.  Identification of human cysteine-rich secretory protein 3 (CRISP-3) as a matrix protein in a subset of peroxidase-negative granules of neutrophils and in the granules of eosinophils.

Authors:  Lene Udby; Jero Calafat; Ole E Sørensen; Niels Borregaard; Lars Kjeldsen
Journal:  J Leukoc Biol       Date:  2002-09       Impact factor: 4.962

9.  Activation of MMP-2, cleavage of matrix proteins, and adherens junctions during a snake venom metalloproteinase-induced endothelial cell apoptosis.

Authors:  Wen-Bin Wu; Tur-Fu Huang
Journal:  Exp Cell Res       Date:  2003-08-01       Impact factor: 3.905

10.  Cysteine-rich secretory protein 3 is a ligand of alpha1B-glycoprotein in human plasma.

Authors:  Lene Udby; Ole E Sørensen; Jesper Pass; Anders H Johnsen; Niels Behrendt; Niels Borregaard; Lars Kjeldsen
Journal:  Biochemistry       Date:  2004-10-12       Impact factor: 3.162

View more
  5 in total

1.  Proteome Analysis of Toxic Fractions of Iranian Cobra (Naja naja Oxiana) Snake Venom Using Two-Dimensional Electrophoresis and Mass Spectrometry.

Authors:  M Samianifard; A Nazari; F Tahoori; N Mohamadpour Dounighi
Journal:  Arch Razi Inst       Date:  2021-03-01

2.  Comparative venomic profiles of three spiders of the genus Phoneutria.

Authors:  Frederico Francisco Fernandes; Juliana Rodrigues Moraes; Jaqueline Leal Dos Santos; Thiago Geraldo Soares; Vitor José Pinto Gouveia; Alessandra C S Matavel; William de Castro Borges; Marta do Nascimento Cordeiro; Suely Gomes Figueiredo; Márcia Helena Borges
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2022-02-09

Review 3.  An Emergent Role for Mitochondrial Bioenergetics in the Action of Snake Venom Toxins on Cancer Cells.

Authors:  Félix A Urra; Dan E Vivas-Ruiz; Eladio Flores Sanchez; Ramiro Araya-Maturana
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

Review 4.  Cysteine-Rich Secretory Proteins (CRISPs) From Venomous Snakes: An Overview of the Functional Diversity in A Large and Underappreciated Superfamily.

Authors:  Takashi Tadokoro; Cassandra M Modahl; Katsumi Maenaka; Narumi Aoki-Shioi
Journal:  Toxins (Basel)       Date:  2020-03-12       Impact factor: 4.546

5.  Evaluation of Signaling Pathways Profiling in Human Dermal Endothelial Cells Treated by Snake Venom Cysteine-Rich Secretory Proteins (svCRiSPs) from North American Snakes Using Reverse Phase Protein Array (RPPA).

Authors:  Montamas Suntravat; Oscar Sanchez; Armando Reyes; Abcde Cirilo; Jack S Ocheltree; Jacob A Galan; Emelyn Salazar; Peter Davies; Elda E Sanchez
Journal:  Toxins (Basel)       Date:  2021-08-31       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.